Treatment with a miR-20b inhibitor significantly increased NLRP3 protein levels and IL-1β and TNF-α secretion in MSU-stimulated THP-1 cells, indicating that miR-20b negatively regulates NLRP3 in an in vitro gouty arthritis model. This evidence concerns the gene NLRP3 and gout.